Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study

Table 1 Clinical characteristics of patient cohort

Patient	Age	ECOG PS	Co-morbidities	Tobacco	T-stage	N-stage	Histology	EGFR	ALK	PD-L1
1	82	1	sciatica	Ex (60 PYH)	2a	2	adenocarcinoma	unk	unk	unk
2	68	1	TIA, hypothyroidism, dyslipidaemia, MS	Ex (unk)	2a	1	squamous cell	N/A	N/A	1–49%
3	83	1	macular degeneration, BPH, dyslipidaemia, HTN	Ex (unk)	4	2	adenosquamous	unk	unk	unk
4	61	2	MI, Raynaud’s	Active	3	2	squamous cell	N/A	N/A	< 1%
5	69	0	N/A	Ex (unk)	3	1	adenocarcinoma	WT	WT	> 50%

(ECOG PS Eastern Cooperative Oncology Group Performance Status, PYH pack year history, unk unknown, WT wild-type, TIA transient ischaemic attack, MS multiple sclerosis, HTN hypertension, BPH benign prostatic hyperplasia, MI myocardial infarction, N/A not applicable)

ISSN: 1748-717X